NotPetya Attack Had Significant Impact on Merck Revenue
“American pharmaceutical giant Merck reported last week that the recent NotPetya malware attack caused losses of hundreds of millions of dollars in revenue.
The company’s financial results for the third quarter show that worldwide sales decreased by 2 percent to $10.3 billion compared to the same quarter of 2016. This was partly blamed on sales reduced by roughly $240 million due to insufficient stock of Gardasil 9, a vaccine designed to prevent certain cancers and other diseases caused by human papillomavirus (HPV).
Merck said it had to borrow the product from the U.S. Centers for Disease Control and Prevention’s Pediatric Vaccine Stockpile due to a higher demand than originally planned and the temporary disruption to production caused by the NotPetya attack.”